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INTRODUCTION 
Skin is a good mirror of internal diseases and gives more 
diagnostic clues than any other organs of the body. A wide range of 
cutaneous signs may be related to internal malignancy. Cancer may 
manifest in the skin as metastasis (e.g., leukemia cutis, cutaneous  
T-cell lymphoma, Paget's disease of the breast), nonspecific metabolic 
effects related to inanition (e.g., wasting, alopecia, xerosis), infections 
related to immunosuppression (e.g., herpes zoster), signs resulting 
from compromise or dysfunction of the affected organ (e.g., jaundice), 
or diverse dermatologic entities called paraneoplastic syndromes, 
which signal that a remote malignancy is present. Cutaneous 
manifestations may develop before a diagnosis of malignancy is 
determined; thus, these findings may aid the physician in the early 
identification of malignancy. 
  It is important to recognize the skin manifestations at the earliest 
for the following reasons. 
1. Their easy accessibility 
2. The skin lesions may be the presenting sign and recognized 
before the primary tumour1. 
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3. The identification of these skin lesions in a known cancer 
patient under remission may be the first indication of 
recurrence. 
4. It indirectly implies the prognosis of the internal malignancy2.  
 A great challenge to the clinician is deciding when an aggressive 
evaluation for an occult malignancy is warranted and when 
conservative management is appropriate. Approximately 70% of 
cancers in patients with a presumed paraneoplastic condition can be 
detected with simple history taking, physical examination, and sex- 
and age-appropriate cancer screening. Unfortunately, most cutaneous 
paraneoplastic syndromes are associated with unresponsive cancers, 
and the prognosis is often poor.  
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REVIEW OF LITERATURE 
 Cutaneous paraneoplastic syndromes represent a 
heterogeneous group of dermopathies whose recognition may allow 
the early detection of occult malignancies. In some cases, the 
relationship between the skin findings and the underlying cancer is 
clearly established, and even the specific type of cancer may be 
revealed. However, other times, the significance of a given 
dermatologic syndrome is controversial.  
There must be a proven association of the cutaneous eruption 
with a tumor. This is not difficult when the supposed manifestation is 
very rare and the tumor is also very uncommon. It becomes a major 
problem, however, when the manifestation is very common, such as 
the seborrhoeic keratoses in the sign of Leser-Trélat, and the 
presumed association is with a wide spectrum of commonly occurring 
neoplasms. In this situation the literature becomes replete with 
anecdotal reports, which may or may not be an indication of whether 
there is a true association with the malignant neoplasm3.  
 There is an evolving consensus of what constitutes a true 
paraneoplastic syndrome. There are two essential criteria : 
1. The dermatosis must develop only after the development of 
the malignant tumor, and 
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2. Both the dermatosis and the malignant tumor follow a parallel 
course, in that complete removal of the cancer results in 
clearing of the dermatosis and recurrence  of the cancer 
causes relapse of the dermatosis. 
These criteria have remained valid but perhaps overly stringent 
because cancers are often difficult to detect, and they may exert subtle 
physiologic influence without their presence being known. Study of 
these syndromes has contributed to the understanding of the biology 
of cancer skin. 
Various attempts have been made to group these manifestations 
in a useful manner, but still our lack of knowledge does not allow us to 
classify these diseases by a pathophysiologic approach in all cases. 
Indeed, there is a very large group where the biochemical relationship 
to the neoplasia is not understood. 
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Cutaneous Manifestations of Internal Malignant Disease3 
I.    Lesions secondary to the deposition of substances in the skin 
          A.    Icterus 
          B.    Melanosis 
          C.    Hemochromatosis 
          D.    Xanthomas 
          E.    Systemic amyloidosis 
II.    Vascular and blood abnormalities 
          A.    Flushing 
          B.    Palmar erythema 
          C.    Telangiectasia 
          D.    Purpura 
          E.    Vasculitis 
          F.    Cutaneous ischemia 
          G.    Thrombophlebitis 
III.    Bullous disorders 
          A.    Bullous pemphigoid 
          B.    Pemphigus vulgaris 
          C.    Paraneoplastic pemphigus 
          D.    Dermatitis herpetiformis 
          E.    Herpes gestationis 
          F.    Erythema multiforme 
          G.    Epidermyolysis bullosa acquisita 
          H.    Linear IgA dermatosis 
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IV.    Infections and infestations 
          A.    Herpes zoster 
          B.    Herpes simplex 
          C.    Bacterial infections 
          D.    Fungi and yeast infections 
          E.    Scabies 
V.    Disorders of keratinization 
          A.    Acanthosis nigricans 
          B.    Acquired ichthyosis 
          C.    Palmar hyperkeratosis 
          D.    Tripe palm 
          E.    Erythroderma 
          F.    Paraneoplastic acrokeratosis of Bazex 
 
VI.    Collagen-vascular disease 
          A.    Dermatomyositis 
          B.    Lupus erythematosus 
          C.    Progressive systemic sclerosis 
VII.    Skin tumors and internal malignant disease 
          A.    Muir-Torre syndrome 
          B.    Gardner's syndrome 
          C.    Cowden disease 
          D.    Mucosal neuroma syndrome 
          E.    Neurofibromatosis 
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VIII.    Hormone-related conditions 
IX.    Disorders associated with primary skin cancer 
          A.    Nevoid basal cell carcinoma syndrome 
          B.    Arsenical manifestations 
X.    Other disorders associated with internal malignant disease 
          A.    Pruritus 
          B.    Erythema gyratum repens 
          C.    Subcutaneous fat necrosis 
          D.    Sweet's syndrome and Neutrophilic dermatoses4 
          E.    Hypertrichosis lanuginosa acquisita 
          F.    Necrolytic migratory erythema 
          G.    Clubbing 
          H.    Peutz-Jeghers syndrome 
          I.    Tuberous sclerosis 
          J.    Multiple eruptive seborrhoeic keratoses 
          K.    Porphyria cutanea tarda 
XI.    Direct tumor involvement in the skin 
A.    Direct Extension 
B.    Local Metastasis 
C.    Distant Metastasis 
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Color Changes Secondary to the Deposition of Substances in the 
skin : 
ICTERUS 
  Icterus as a manifestation of internal malignancy is generally a 
late sign. It is usually secondary to obstruction of the bile duct or gross 
intrahepatic obstruction. Extrahepatic obstruction can be secondary to 
malignant disease of the gall bladder, pancreas, bile duct, or adjacent 
bowel. 
Melanosis 
Melanosis is a condition caused by the abnormal deposition of 
melanin pigments in tissue. It is externally manifested by a diffuse 
gray-brown pigmentation of the skin. A mild darkening of the skin may 
be seen with adrenal insufficiency, with ACTH-producing tumors such 
as primary tumors of the pituitary gland, or with other malignant tumors 
metastatic to the pituitary gland6. 
Diffuse melanosis and pigment streaks in the nail plate can also 
be secondary to malignant melanoma. Usually occurring late in the 
disease course, melanosis can, however, be the presenting sign. 
Andreev and Petkov noted a melasma (chloasma) type of 
hyper pigmentation on the face of five patients with “brain tumors7.” In 
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three patients the hyper pigmentation resolved after the surgical 
removal of the tumor. 
Hemochromatosis 
A diffuse gray-brown pigmentation of the skin can also be 
produced by Hemochromatosis. A third of untreated patients with 
hemochromatosis will develop hepatocellular carcinoma8. 
Xanthomas 
The predominant type of xanthoma associated with internal 
malignant disease is the plane xanthoma. The most common 
association of diffuse plane xanthoma is with multiple myeloma. 
Xanthomas, as well as atypical eruptive histiocytosis with lipid 
deposition, have also been associated with myelocytic leukemia, 
myelomonocytic leukemia, leukemic lymphocytic reticuloendotheliosis, 
diffuse histiocytic lymphoma, and the cutaneous T cell lymphoma9, 10. 
Juvenile xanthogranuloma can be associated with juvenile chronic 
myeloid leukemia11. 
Purpura may be a feature of diffuse plane xanthomas associated 
with malignant disease. Pinch purpura has been noted in a 
normolipidemic patient with myeloma. Hemorrhagic bullae have been 
associated with xanthoma disseminatum and IgG K type multiple 
myeloma12.  
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Systemic Amyloidosis  
Systemic amyloidosis of both the primary type and that 
associated with multiple myeloma commonly has skin lesions. It is 
important to differentiate skin lesions of systemic amyloidosis from the 
far more commonly seen purely cutaneous variants of amyloidosis. All 
patients with skin lesions of systemic amyloidosis should be thoroughly 
investigated for multiple myeloma. Acute nonlymphocytic leukemia has 
also been reported in association with systemic amyloidosis treated 
with melphalan13. 
Intradermal bullae have been associated with myeloma-related 
amyloidosis. These bullae are the result of extensive dermal infiltration 
with amyloid, resulting in cleavage of the uppermost dermis from the 
lower dermis. 
Vascular and Blood Abnormalities 
FLUSHING 
   Acquired pronounced flushing, usually of the central face and 
upper trunk, may be a manifestation of carcinoid syndrome, caused by 
carcinoid tumors14. 
Vasoactive substances can also be released in patients with 
extensive localized or systemic mastocytosis and in patients with 
pheochromocytoma. Unilateral flushing and sweating (harlequin 
 
 
11
syndrome) have been associated with a contralateral lung cancer 
invading the spine, in a patient with Pancoast's syndrome, and with 
Horner's syndrome15. 
Palmar Erythema 
Palmar erythema can be associated with advanced liver failure. 
Such liver failure may be secondary to either a primary or a metastatic 
tumor in the liver. 
Telangiectasia 
Localized, grouped telangiectatic vessels on the anterior chest 
wall may be a marker for breast cancer. There is often a clinically 
palpable, indurated, warm, subcutaneous plaque immediately beneath 
the telangiectatic area. Generalized telangiectasia can be a presenting 
factor of malignant angioendotheliomatosis .Progressive 
telangiectases have been associated with carcinoid tumors and with 
adenocarcinoma of the hepatic bile duct16. 
Telangiectasia may also be a manifestation of a 
genodermatosis, which in turn can be associated with systemic 
malignant disease such as lymphoma.These genodermatoses include 
ataxia-telangiectasia, Bloom's disease, and xeroderma pigmentosum 
and its variant De Sanctis-Cacchione syndrome . In addition to the 
well-known association of lymphocytic leukemia and non-Hodgkin's 
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lymphoma in patients with ataxia-telangiectasia, there appears to be 
an increased incidence of solid tumors of the oral cavity, breast, 
stomach, pancreas, ovary, and bladder, as well as others17. Female 
heterozygotes of ataxia-telangiectasia have a significantly increased 
risk of breast cancer18. 
Purpura 
Lymphoma is the most common cause of idiopathic 
thrombocytopenic purpura (ITP) associated with malignant disease. 
Hodgkin's disease is the most common associated lymphoma, and the 
diagnosis of ITP may precede other evidence of lymphoma. 
Purpura related to cancer can occur from a wide variety of 
mechanisms: thrombocytopenia, consumption coagulopathy, hyper- or 
dysglobulinemia, vascular fragility, and vasculitis. 
Disseminated intravascular coagulation (DIC) as a cause of 
purpura in malignant disease is most commonly associated with acute 
lymphocytic or myelomonocytic leukemia, in particular T cell acute 
lymphocytic leukemia19. Many patients may not have full-blown DIC, 
having only biochemical or mild clinical manifestations of the process. 
Thrombotic thrombocytopenic purpura, when associated with cancer, 
is usually a late sign. 
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Purpura can also be associated with the hyperglobulinemia seen 
in multiple myeloma or lymphoma. When purpura is secondary to the 
presence of cryoglobulins, lesions are often found in acral areas and 
may be associated with Raynaud's phenomenon. Benign 
hyperglobulinemic purpura can be associated with Sjögren's 
syndrome, which in turn can be associated with malignant disease. 
Purpura, usually palpable, is a clinical sign of cutaneous 
vasculitis, which in turn can be associated with cancer. It is important 
not to forget that a bacterial septicemia can present as a palpable 
purpuric eruption in patients with cancer. 
Vasculitis 
Leukocytoclastic vasculitis, such as can be seen in Henoch-
Schönlein purpura, can be very rarely associated with malignant 
neoplasms. It can be a presenting sign in squamous cell carcinoma, 
particularly of the bronchus20, and in renal carcinoma21. 
Leukocytoclastic vasculitis can also be associated with leukemia and 
leukemic lymphoma22. 
A periarteritis nodosa–like syndrome has also been reported in 
association with hairy cell leukemia, acute lymphocytic leukemia, and 
multiple myeloma23, 24. 
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Cutaneous Ischemia 
  Evidence of compromised peripheral circulation can be a marker 
for many malignant neoplasms. It is frequently manifested by evidence 
of digital ischemia, either as Raynaud's phenomenon or frank 
gangrene. Peripheral ischemia has been associated with many 
malignant neoplasms, including carcinoma of the pancreas, stomach, 
small bowel, ovary, and kidney, as well as lymphoma and leukemia25. 
The peripheral cutaneous ischemia secondary to the increased 
viscosity of the peripheral circulation can be seen in Polycythemia 
Rubra Vera26, Leukemia, multiple myeloma and with lymphoma. 
Thrombophlebitis 
  Isolated vein thrombophlebitis is uncommonly associated with 
internal malignant disease. Multiple-lesion “migratory” superficial 
thrombophlebitis is much more often seen in association with cancer, 
and when this syndrome is present the patient should be examined 
carefully for occult malignant disease. The association of peripheral 
thrombophlebitis with gastric carcinoma was noted by Trousseau in 
the nineteenth century. 
Migratory superficial thrombophlebitis as a marker for cancer 
has been confirmed, and the association has been extended to include 
tumors of the pancreas, prostate, lung, liver, bowel, gallbladder, and 
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ovary, as well as to lymphoma and leukemia. The migratory nature of 
the thrombophlebitis probably relates to a generalized 
hypercoagulable state. 
BULLOUS DISORDERS 
Bullous Pemphigoid 
There is probably no significantly increased risk of a malignant 
tumor in patients with bullous pemphigoid, other than that associated 
with the age of the patient27, although a Japanese cohort of patients 
with bullous pemphigoid had a 5.8 percent prevalence of neoplasia, 
versus 0.61 percent of controls28.  
Pemphigus 
Pemphigus vulgaris can be associated with Hodgkin's disease, 
in which case the two diseases can run a parallel course29. The 
relationship of solid tumors to pemphigus vulgaris is less well defined.  
There is a well-defined association of pemphigus with thymoma, 
with or without clinical myasthenia gravis30, 31, 32, 33. 
Paraneoplastic pemphigus34 is clinically, histopathologically, and 
immunopathologically a distinct form of pemphigus with features of 
erythema multiforme. It has been described in association with 
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lymphoma, chronic lymphocytic leukemia, thymoma, sarcoma, and 
Waldenström's macroglobulinemia; it has a very poor prognosis. 
Dermatitis Herpetiformis 
Dermatitis herpetiformis is occasionally associated with intestinal 
lymphoma. The relative risk of non-Hodgkin's lymphoma associated 
with dermatitis herpetiformis is 5.4 (2.2 to 11.1) in males, less in 
females35. Patients with dermatitis herpetiformis have gluten 
sensitivity, and the presumed etiology of the lymphoma is the resulting 
chronic antigenic stimulation.  
Linear IgA Dermatosis 
Linear IgA dermatosis has been reported in association with 
lymphoma, chronic lymphocytic leukemia, myeloma, carcinoma of the 
bladder and esophagus, and with hydatidiform mole40,41. 
Herpes Gestationis 
Herpes gestationis has been described in association with a 
hydatidiform mole36 and germ cell tumor37. 
Erythema Multiforme 
Erythema multiforme does not appear to be a specific marker for 
any internal neoplasm. It appears to occur more frequently in patients 
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with acute leukemia, but whether this relates to the leukemia or to its 
treatment has not been well defined. 
Epidermolysis Bullosa Acquisita 
Epidermolysis bullosa acquisita is a very rare disorder that has 
been described rarely in association with carcinoma of the bronchus 
and with amyloidosis and multiple myeloma39.   
INFECTIONS AND INFESTATIONS 
Herpes Zoster 
Only a small percentage of patients with localized herpes zoster 
have a concurrent malignant disease, and investigation for malignant 
disease in otherwise healthy patients is not indicated. Patients with 
leukemia or lymphoma do have an increased risk of herpes zoster, but 
the herpes zoster usually occurs late in the course of their disease. 
The incidence of herpes zoster in patients with lymphoma is 
approximately 10 percent, possibly even higher in patients with 
Hodgkin's disease42. 
Localized herpes zoster can also occur in association with solid 
tumors such as breast cancer. In the case of breast cancer, the 
dermatomal distribution of the herpes zoster may indicate involvement 
of the nerve root area with metastatic tumor. The site of the primary 
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tumor correlates with the site of herpes zoster in patients with breast 
cancer, cancer of the respiratory tract, and gynecologic cancer. 
Segmental herpes zoster can also occur after radiation therapy, 
presumably secondary to nerve damage with subsequent viral 
activation. 
Disseminated herpes zoster is commonly associated with 
underlying malignant disease. Any patient with disseminated herpes 
zoster that is otherwise unexplained should be carefully examined for 
evidence of cancer. 
The most commonly associated malignant diseases are 
lymphoma and leukemia43. The development of herpes zoster in a 
previously treated lymphoma patient can be evidence of the 
recurrence of a lymphoma. This sign is of particular value in patients 
who develop the herpes zoster more than 6 months after clinical 
remission42. 
Herpes Simplex 
Typical localized herpes simplex is rarely a marker for cancer. 
Extensive, often chronic, local herpes simplex with massive ulceration 
and destruction of tissue, generalized cutaneous herpes simplex, and 
disseminated systemic herpes simplex are indeed associated with 
malignant disease, which is often far advanced. Lymphoma and 
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leukemia are most often the associated cancers, but any advanced 
malignant tumor can produce the compromised host immune response 
associated with these conditions44. 
Bacterial Infections 
Bacterial infection of the skin as a marker for the presence of 
internal malignancy is very uncommon, and when it is associated with 
malignancy, it is usually associated with very advanced disease.] 
Fungi and Yeast 
Dermatophyte infections of the skin are not associated with 
internal malignant disease. Deep fungal infections, with their 
associated skin lesions, can be associated with malignant disease. 
Similarly, mucosal candidiasis usually indicates a severely 
compromised host immune response, which can be secondary to 
advanced malignant disease or to chemotherapy. 
Scabies 
Norwegian scabies, a severe generalized form of scabies, is 
associated with the leukemia-lymphoma group of neoplasms, but it 
can be seen in any severely immunocompromised host. The scabies is 
frequently manifested by a minimal inflammatory response and should 
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always be considered in patients who have advanced malignant 
disease associated with pruritus. 
DISORDERS OF KERATINIZATION  
Acanthosis Nigricans 
Acanthosis nigricans can be classified into two major groups: 
benign and malignant. Malignant acanthosis nigricans is usually of 
sudden onset and is rapidly progressive, but it is otherwise clinically 
indistinguishable from benign acanthosis nigricans .Diffuse 
keratoderma involving the palms, soles, and flexor surfaces of the 
fingers and toes may be more common in malignant acanthosis 
nigricans than in the benign form. Such changes can be early. 
Malignant acanthosis nigricans is usually secondary to an 
intraabdominal adenocarcinoma45,46. There is evidence that malignant 
acanthosis nigricans is linked to an enhanced secretion by the cancer 
of transforming growth factor alpha47.  
Acquired Ichthyosis.  
  Acquired ichthyosis (AI) is extremely rare and is virtually 
clinically indistinguishable from autosomal dominant ichthyosis 
vulgaris. Both conditions manifest with small white to brown polygonal 
scales that lift up at the free edge and are widely distributed on the 
 
 
21
trunk and extensor surfaces of the extremities. The palms and soles 
are usually spared.  
  The sudden onset of ichthyosis in an adult may indicate an 
occult malignant tumor. AI is most strongly associated with Hodgkin 
lymphoma; as many as 70% of cases of paraneoplastic AI involve 
Hodgkin disease. Other AI-associated malignancies include Kaposi 
sarcoma, cutaneous T-cell lymphoma, non-Hodgkin lymphoma, 
leukemias, and solid tumors (including those arising in breasts, lungs, 
or bladder). The ichthyosis is a true hyperkeratosis and can be 
differentiated clinically and histologically from simple dry skin xerosis. 
Palmar Hyperkeratosis 
There are two groups of patients with palmar hyperkeratosis and 
associated malignant tumors: those patients with diffuse palmar 
hyperkeratosis and those with punctate palmar hyperkeratosis. 
In 1958, diffuse hyperkeratosis, or tylosis, was reported by 
Howel-Evans et al48 to be associated in two families with an almost 
certain development of esophageal carcinoma by age 65. The tylosis 
in these patients can be separated clinically from the benign form of 
tylosis, which occurs at an earlier age (early childhood), has sharply 
delimited edges, and is of uniform thickness. In addition to the Howel-
Evans families, there would appear to be a greater than expected 
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incidence of esophageal carcinoma in other families with a pedigree of 
tylosis49. A large kindred has been described with palmoplantar 
keratoderma in association with breast or ovarian carcinoma, or both50. 
The second type of palmar hyperkeratosis that may be 
associated with neoplasia consists of discreet hyperkeratotic papules 
on the palms. These patients have been reported to have a greater 
than expected risk of cancer of the breast and uterus, among other 
tumors51,52. Palmar hyperkeratosis is also seen in paraneoplastic 
acrokeratosis of Bazex. 
Tripe Palm 
Tripe palm is a rugose thickening of the palms that is strongly 
associated with internal cancer53. The honeycombed and corrugated 
thickening of the palms may be associated with periungual 
tenderness54. Normal dermatoglyphic ridges are accentuated. The 
most common cancers associated with tripe palms are carcinomas of 
the stomach and lung, with fewer occurrences being noted with other 
solid tumors55.  
Erythroderma 
Erythroderma, a diffuse erythema of the skin surface usually 
associated with induration and scaling, is not uncommonly associated 
with malignancy, most commonly hematologic, in particular leukemia 
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and lymphoma where there is direct infiltration of the skin by the 
malignant cells. The cells are most frequently lymphocytes of T cell 
type. Among solid tumors, erythroderma has been associated with 
carcinoma of the lung, liver, prostate, thyroid, colon, pancreas, and 
stomach.  
Paraneoplastic Acrokeratosis of Bazex 
Paraneoplastic acrokeratosis of Bazex is a symmetric 
dermatosis that most commonly affects the hands, feet, ears, and 
nose with an erythematous psoriasiform eruption. Acanthosis nigricans 
may be an associated finding. The nails are involved early and 
severely. There is subungual hyperkeratosis and flaky white surface of 
the nail. The nails may be shed. The distal digits show an 
erythematous scaling eruption, often fissured and often with 
suppuration56,57. Bazex syndrome is almost always associated with 
cancer, and is commonly seen in males58. It is usually associated with 
neoplasia of the upper respiratory system, which includes the pharynx, 
esophagus, tongue, and lungs, although rarely other solid tumors have 
been reported in association.  
COLLAGEN-VASCULAR DISEASE 
Dermatomyositis 
  Dermatomyositis can be a marker for internal neoplasia, and the 
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development of the dermatomyositis can predate the diagnosis of the 
cancer. The malignancies associated with DM are those common for 
the age, racial background, and sex of the patient, although incidences 
of ovarian, cervical, lung, and pancreatic and gastric carcinomas, in 
addition to non-Hodgkin lymphoma, may be unusually increased.  
Clinical features of DM that may increase the likelihood of 
cancer include (1) a normal serum creatine kinase level, (2) disease 
that is refractory to treatment, (3) an absence of myositis antibodies, 
(4) overlap of autoimmune disease and lung disease, and (5) 
cutaneous necrosis. A review of the literature reveals that cancer risk 
is associated with increased age (>65 y), necrotic truncal lesions, the 
presence of cutaneous leukocytoclastic vasculitis, and capillary 
damage seen in muscle biopsy samples. Pediatric DM is only rarely 
associated with internal malignancy.  
Lupus Erythematosus 
Systemic lupus erythematosus (SLE) is only rarely associated 
with malignant neoplasia, most often with lymphoma or thymoma. 
Pemphigus erythematosus has been noted in association with 
malignant thymoma and myasthenia gravis, as has a pemphigus 
vulgaris–like eruption and positive LE cell test . 
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Scleroderma 
Systemic scleroderma is not commonly associated with internal 
malignancy. In 727 cases of systemic scleroderma, only 2.6 percent 
had an internal malignant lesion59. The only tumor that has been found 
to be consistently associated with scleroderma is carcinoma of the 
lung60. Almost all patients with associated lung tumors have very 
advanced systemic scleroderma. The association is most likely one of 
a lung tumor developing secondary to the chronic pulmonary fibrosis. 
SKIN TUMORS AND INTERNAL MALIGNANT DISEASE 
Muir-Torre Syndrome 
The essential features of the Muir-Torre syndrome are 
sebaceous tumors of the skin, with or without keratoacanthomas, in 
association with visceral neoplasms, which are often multiple61,62. 
Colon cancers are particularly common and may be associated with 
colonic polyposis61,62,63,64,65. Other neoplasms include other tumors of 
the gastrointestinal tract and tumors of the larynyx and endometrium. 
A solitary benign sebaceous gland tumor of the eyelid is a good 
marker for the Muir-Torre syndrome and that its presence warrants 
review for systemic cancer.  
 
 
 
26
Gardner's Syndrome 
The essential features of Gardner's syndrome are intestinal 
polyposis (usually colonic), with a high rate of malignant 
transformation; epidermoid cysts, particularly of the face, scalp, and 
trunk; osteomatosis of the maxilla, mandible, and cranial bones; and 
fibromas, desmoids, and other fibrous tumors of the skin and 
subcutaneous tissue66. There is an association of hepatoblastoma, a 
rare neoplasm of infants and children with Gardner's syndrome, and 
there may be some overlap of the features of Gardner's syndrome and 
nevoid basal cell carcinoma syndrome67.  
Cowden Disease 
Cowden disease, or multiple hamartoma syndrome, inherited 
as an autosomal dominant trait, the distinctive cutaneous lesions are 
multiple tricholemmomas. These lesions are grouped around 
the mouth, nose, and ears and clinically resemble warts. Other 
cutaneous lesions can include lipomas, hemangiomas, neuromas, 
vitiligo, café au lait lesions, and acromelanosis68. Angioid streaks may 
be present in the retina. 
Patients with Cowden disease have a greatly increased risk of 
breast and thyroid carcinoma. The breast changes seen in women 
range from fibrocystic disease to adenocarcinoma and can occur at a 
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young age. Prophylactic mastectomy may be indicated69. Thyroid 
adenoma is the most common thyroid tumor, but thyroid carcinoma 
can develop. Gastrointestinal tract polyposis is common70. There may 
also be an increased risk of gastrointestinal malignancy.  
Mucosal Neuroma Syndrome 
 Mucosal neuroma syndrome is probably a variant of multiple 
endocrine neoplasia, type 2 (MEN 2 or 2A, Sipple's syndrome). Also 
designated MEN 3 or MEN 2B, the typical features include oral, nasal, 
upper gastrointestinal tract, and conjunctival neuromas, associated 
with medullary thyroid carcinoma (MTC) and pheochromocytoma. The 
appearance of the neuromas usually precedes the development of 
cancer, but the MTC can appear in early childhood. The 
pheochromocytomas are often bilateral. Unlike MEN 2, parathyroid 
hyperplasia is rare. 
Neurofibromatosis 
  Von Recklinghausen's neurofibromatosis has many associated 
malignant tumors71. Malignant schwannoma is the most common, 
occurring in one series in 29 percent of patients72. These patients were 
usually over the age of 30. Other tumors include fibrosarcoma, 
rhabdomyosarcoma, nephroblastoma (Wilms' tumor), and acute and 
chronic myelogenous leukemia. There is an increased incidence of 
 
 
28
ocular melanoma, with anecdotal reports of cutaneous melanoma. 
Benign neural tumors, peripheral and intracranial, are common. 
HORMONE-RELATED CONDITIONS 
  Malignant tumors may release hormones into the circulation, 
and such hormones can produce skin manifestations. The 
manifestation of such hormone excess is not specific to the tumor and 
can occur secondarily from an excess of that hormone from any cause. 
Hirsutism may be a manifestation of an increase in circulating 
androgens. Such androgen excess is most typically seen with 
testicular or ovarian tumors.  
Gynecomastia in the male can be produced by an excess of 
estrogens. Such estrogens may be produced by a tumor of the testis. 
Lung tumors can also produce gynecomastia. 
Cushing's syndrome is generally secondary to excessive ACTH 
production. Tumors from widely diverse sites can produce excessive 
ACTH. Many of these are derived from APUD tissue. The most 
common site is the lung, with the pancreas being the next most 
common. 
Acne can be caused by the same tumors that produce hirsutism. 
Acne may also be a marker for internal malignancy in another way. 
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Female patients with severe acne show an apparent increase in the 
incidence of breast cancer73.  
OTHER DISORDERS ASSOCIATED WITH PRIMARY SKIN 
CANCERS 
Nevoid Basal Cell Carcinoma Syndrome 
Nevoid basal cell carcinoma syndrome, or Gorlin-Goltz 
syndrome, is a syndrome consisting of multiple basal cell carcinomas, 
jaw cysts, skin pitting, skeletal abnormalities, and a tendency to 
malignant disease74. The most common malignant tumor is 
medulloblastoma75. These tumors can occur in patients without any 
cutaneous basal cell carcinomas but with a family history of nevoid 
basal cell carcinoma syndrome. Other tumors include astrocytomas, 
meningiomas, and craniopharygiomas.  
Arsenical Manifestations 
Chronic arsenic toxicity can be manifested by arsenical 
melanosis, plantar and palmar keratoses, and Bowen's disease. There 
would also appear to be an increased risk of internal neoplasia. The 
increased cancer risk was originally estimated to be to nine times the 
expected incidence. Approximately one-third of patients with Bowen's 
disease developed an internal malignancy 6 to 10 years after their 
initial diagnosis76. Malignancies have included tumors of the urogenital 
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region, mouth, esophagus, and lung. Arsenical keratoses on the palms  
and soles, a more specific finding, did correlate with an apparent 
increase in internal malignancy77.  
OTHER DISORDERS ASSOCIATED WITH INTERNAL MALIGNANT 
DISEASE 
Pruritus 
  Pruritus, often accompanied by excoriations, can be a 
nonspecific marker of internal malignant disease. Although often 
associated with xerosis, the pruritus of malignant disease can occur 
in apparently normal skin. It can be continuous or paroxysmal. It is 
usually generalized. 
When occurring with malignant diseases, pruritus is most 
commonly associated with leukemia and lymphoma, including drug 
induced lymphoma78. Pruritus is one of the most common cutaneous 
manifestations of leukemia, probably exceeded only by purpura. It is 
usually less severe than that associated with lymphoma and is more 
often generalized.  Pruritus associated with bathing is a marker for 
polycythemia rubra vera and is present in half of patients79. This itch 
can be severe and paroxysmal. Patients with polycythemia rubra vera 
can also have chronic continuous pruritus unrelated to bathing. 
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Severe pruritus can be a feature of Fanconi's anemia and 
myeloma. Pruritus associated with visceral neoplasia is most 
commonly associated with pancreatic and stomach tumors80 but may 
also be associated with most other solid tumors. The appearance of 
severe pruritus after treatment of the primary tumor may herald a 
tumor recurrence. Renal and liver involvement with primary or 
metastatic cancer can also produce pruritus secondary to the 
accumulation in the skin of pruritogenic metabolites. 
Erythema Gyratum Repens 
Erythema gyratum repens is a cutaneous eruption consisting of 
concentric raised erythematous bands moving in waves over the body 
surface in a “wood-grain” pattern81. The erythematous bands may be 
flat or raised. Removal of the malignant tumor usually results in 
complete resolution of erythema gyratum repens within 6 weeks. 
Almost all cases of erythema gyratum repens, which is 
extremely rare, are associated with internal malignancy. Although first 
described with carcinoma of the breast81, erythema gyratum repens 
has also been found in association with tumors of the lung82, bladder, 
prostate, cervix, stomach, and esophagus and with multiple myeloma. 
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Subcutaneous Fat Necrosis 
Subcutaneous fat necrosis is a cutaneous marker for acinar cell 
carcinoma of the pancreas. Intraosseus fat necrosis can also occur83, 
with the production of osteolytic lesions visible on x-ray examination. 
The polyarthralgia is presumably the result of fat necrosis of the 
periarticular tissue. There is frequently a concomitant associated fever 
and eosinophilia. 
Sweet's Syndrome and Neutrophilic dermatoses 
In Sweet syndrome,also termed acute febrile neutrophilic 
dermatosis84, clinical lesions range from generalized crimson, 
agminate papules, to large red to purple-red plaques, to lesions that 
are truly bullous in nature, and to lesions that are indistinguishable 
from pyoderma gangrenosum. The skin lesions usually erupt suddenly. 
Malignancy associated Sweet's syndrome is most commonly seen with 
acute myelocytic leukemia but may also be observed in acute 
myelomonocytic leukemia, myelodysplastic syndrome, chronic 
myelogenous leukemia, acute lymphoblastic leukemia, chronic 
lymphocytic leukemia, hairy cell leukemia, multiple myeloma, and 
lymphoma. 
Pyoderma gangrenosum, particularly in a superficial and bullous 
form, has been associated with myeloproliferative diseases, including 
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acute and chronic myeloid leukemia, acute lymphocytic leukemia, 
myeloid metaplasia, PRV, multiple myeloma, lymphoma and 
myelofibrosis85,86. Solid tumours reported included carcinoid, colon, 
bladder, prostate, breast, bronchus, ovary and adrenocortical 
carcinoma86.   
Hypertrichosis Lanuginosa Acquisita 
Hypertrichosis lanuginosa acquisita (HLA) is an acquired 
excessive growth of lanugo (vellus) hairs. Fully expressed HLA is 
usually secondary to malignant tumors, but excessive lanugo hair 
growth can also be caused by drugs such as exogenous steroids, 
phenytoin, diazoxide, streptomycin, penicillamine, cyclosporine, and 
minoxidil or by conditions such as anorexia nervosa. 
HLA secondary to malignancy is usually abrupt in its onset and 
is rapidly progressive. Associated tumors reported include tumors of 
the colon (including carcinoid tumors), rectum, bladder, lung, 
pancreas, gallbladder, uterus,  breast and lymphoma87,88,89.  
Necrolytic Migratory Erythema 
Necrolytic migratory erythema is a marker for an alpha-2-
glucagon- producing islet cell tumor of the pancreas90,91,92. It is 
manifested by erythema, vesicles, pustules, bullae, and erosions, 
which typically involve the face, the intertriginous areas, in particular 
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the groin, and the perigenital region . It also involves the shins, ankles, 
and feet as well as the fingertips. Most patients with necrolytic 
migratory erythema have a pancreatic tumor of the glucagon-
producing type. Resection of the tumor clears the eruption, sometimes 
within 48 h.   
Clubbing 
Clubbing is the soft tissue enlargement of the tips of the fingers 
and toes. More typically associated with chronic lung disease, it can 
also be associated with neoplasms of the chest, usually bronchogenic 
carcinoma. Five to ten percent of patients with bronchogenic 
carcinoma develop clubbing93. Mesothelioma can also produce similar 
changes. Clubbing can also be produced by other solid tumors 
metastatic to the thorax and has been reported in Hodgkin's disease of 
the lung. Clubbing can also be seen with diffuse intestinal lymphoma. 
Peutz-Jeghers Syndrome  
The association of cutaneous and mucosal hyperpigmentation 
with gastrointestinal tract polyposis is now well known94,. The skin 
hyperpigmented macules are usually present at birth or early infancy 
and frequently fade at puberty. They can be typically grouped around 
the mouth, eyes, and nostrils, with pigmented macules also located on 
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the fingers, palms, toes, periumbilical skin, or diffuse over the skin 
surface. Mucosal pigmented lesions are similar but persist for life.  
The most common malignancy associated with the Peutz-
Jeghers syndrome is duodenal carcinoma. These malignant tumors 
are frequently associated with hamartomatous polyps. The lifetime risk 
of a patient with Peutz-Jeghers syndrome developing an upper 
gastrointestinal tract malignancy carries an overall cancer relative risk 
of up to 1894. 
Tuberous Sclerosis 
Tuberous sclerosis can be associated with tumors within many 
organ systems. Most of these are hamartomatous, and some of these 
can become malignant. However, malignant transformation in tuberous 
sclerosis is uncommon, occurring in probably no more than 5 percent 
of patients. 
Multiple Eruptive Seborrhoeic Keratoses 
 Multiple eruptive seborrhoeic keratoses, also known as the sign 
of Leser- Trélat, have been mentioned in association with multiple 
internal malignancies95. These malignancies have included tumors of 
the stomach, breast, prostate, lung, and colon and malignant 
melanoma, as well as many references to their occurrence in 
lymphoma, primary lymphoma of the brain, and mycosis fungoides, 
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including Sézary syndrome. Evidence to support the presumed 
relationship of seborrheic keratoses to malignant disease is meager96. 
Most of the cancers described in association are common; seborrheic 
keratoses are common. Proving an uncommon causal relationship 
between a common cancer and a common skin sign is difficult. 
Porphyria Cutanea Tarda 
Porphyria cutanea tarda has been associated with the 
development of malignant tumors, predominantly of the liver. The 
relative risk of hepatocellular carcinoma in patients with porphyria 
cutanea tarda has been estimated as 6197, a truly significant 
association. The porphyria cutanea tarda can predate or antedate the 
apparent development of the primary liver tumor. 
DIRECT TUMOR INVOLVEMENT IN THE SKIN 
Direct involvement of the skin by metastatic spread from a 
distant primary tumor is perhaps the most unquestioned marker for the 
internal malignancy. In a large review by Lookingbill et al98 skin 
involvement was the first sign of cancer in 0.8 percent of systemic 
cancer patients. Of this group, approximately equal numbers had 
direct extension to the skin, local metastases, or distant skin 
metastases.  
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It may be a indication for recurrence with known primary. It may 
be a presenting lesion of an unsuspected malignancy . It usually occur 
on skin in the vicinity of affected organ.It is commonly seen in older 
age group.    
   Cancers that have the highest propensity to metastasize to the 
skin include melanoma (45% of cutaneous metastasis cases), breast 
(30%), nasal sinuses (20%), larynx (16%), and oral cavity (12%). 
Because breast cancer is so common, cutaneous metastasis of breast 
cancer is the most frequently encountered type of cutaneous 
metastasis in most clinical practices. Although some tumors are very 
common, they may not necessarily eventuate in metastasis in a 
manner that parallels their incidence in the overall population. For 
example, prostate cancer is very common, but cutaneous metastasis 
from prostate carcinoma is relatively uncommon. 
  Direct extension was most common in patients with breast and 
oral cancer. Local metastases were most common in patients with 
breast cancer or pelvic cancer. Distant metastases were from lung, 
colon, stomach, upper aerodigestive tract, uterus, kidney & 
lymphoma3.  
Generally such a metastatic lesion is obvious, being an 
erythematous cutaneous or subcutaneous mass, and is frequently 
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rapidly growing. At times, it can be difficult to diagnose metastatic 
lesions especially with metastases from breast cancer. 
Carcinoma Breast 
Most commonly breast cancer lesions metastasize to the 
anterior chest wall. They can typically show up as small nodules 
ranging from tiny 1- to 2- mm lesions to large masses of tumor. The 
tiny nodules can be erythematous or can be frankly hemorrhagic. The 
hemorrhage can be present within the nodules or in the field 
surrounding the nodules. The various morphologic variants of 
cutaneous metastases observed with Carcinoma breast are 
Carcinoma Erysipeloides(Inflammatory Carcinoma),Nodular metastatic 
carcinoma, En cuirasse metastatic Carcinoma, Carcinoma 
telangiectatica and Carcinoma of inframammary crease. 
Paget's disease of the nipple is an erythematous scaling 
eruption that indicates ductal carcinoma of the underlying breast. 
Lung Cancer  
Lung cancer is the most common cause for cutaneous  
metastasis in men. The commonest site for cutaneous metastases in 
men is the chest, followed by the abdomen and the back. Other areas 
(in decreasing order of frequency) include the scalp, the neck, the 
face, the extremities, and the pelvis. For women, the most common 
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areas (in decreasing order of frequency) are the chest, the abdomen, 
the back, and the upper extremities.  
Gastrointestinal cancers (usually colon and stomach cancer)   
They often metastasize to the abdomen and the pelvis. 
Gastrointestinal carcinomas may spread along the urachus and 
produce nodules at the umbilicus. The presentation of nodules at the 
umbilicus has been referred to as a Sister Mary Joseph nodule. Sister 
Mary Joseph was a nurse at the Mayo Clinic who helped to prepare 
patients prior to operation for gastrointestinal surgery. She noted that 
the nodules at the umbilicus were an ominous sign of extensive 
involvement of colorectal carcinoma.  
Malignant Melanoma 
  About 60,000 Americans develop malignant melanoma each 
year, but only 9000 deaths are attributed to malignant melanoma 
annually in the United States. When malignant melanoma 
metastasizes, the skin is commonly involved. In men, melanomas are 
likely to metastasize to the chest, the extremities, and the back. A 
large portion of female patients have metastases to the lower 
extremities. Metastases of melanoma may simulate blue nevi and may 
be epidermotropic or simulate primary cutaneous melanoma. 
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Neoplasm of Oral Cavity 
Cutaneous metastases from squamous cell carcinoma in the 
oral cavity usually remain in the local area, most often affecting the 
neck and the face.  
Renal Tumours  
 Renal cell carcinoma may metastasize to the scalp, to operative 
scars, or on many other surfaces. Because of the prominent vascular 
supply of renal cell carcinoma, lesions may mimic a hemangioma or a 
pyogenic granuloma, sometimes it can be pulsatile. 
Neoplasm of Genital Tract 
  Metastases from the ovary and the uterus are seen in the skin of 
the lower abdomen, the groin, or the upper thigh.  
Neoplasm of Endocrine glands 
Metastases thyroid carcinoma may be pulsatile and may have a 
bruit. 
Lymphoma-Leukemia 
  Involvement of the skin with lymphoma cells is quite common, 
particularly in the case of a T cell lymphoma3. T cell leukemias 
frequently have skin involvement, and this involvement may manifest 
itself as a diffuse erythroderma as is seen in Sézary syndrome. 
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B cell lymphomas can also involve the skin, with Hodgkin's 
disease being the most common. B cell lymphoma involvement of the 
skin is usually manifested by the development of one or more papules 
or nodules that may be ulcerated and form arcuate lesions. Alopecia 
can also be caused by lymphoma. Alopecia mucinosa is involvement 
of the hair follicles by lymphoma, with associated mucin deposition. 
 Other lymphocytic, myeloid, and myelomonocytic leukemias can have 
cutaneous manifestations. The most common of these are the 
infiltrations of the skin produced by monocytic or myelomonocytic 
leukemia, which can produce a  leonine facies in addition to other 
infiltrative plaques. Involvement of the skin can be a presenting feature 
in myelomonocytic leukemia, although it generally occurs late in the 
course of the disease. Multiple myeloma can appear as small red 
nodules on the skin surface with diagnostic myeloma histology. 
Extra Mammary Paget's Disease 
Extramammary Paget's disease, which can occur in the 
anogenital skin, similarly may be associated with an underlying 
adenocarcinoma. The underlying carcinoma may be of apocrine or 
eccrine sweat gland origin, or can be from the rectum or urethra3. 
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AIM OF THE STUDY 
1. To study the incidence of Cutaneous Manifestations in patients 
with internal Malignancy. 
2. To study the age & sex predilection of Cutaneous Manifestations 
in patients with internal Malignancy. 
3. To study the incidence of specific and non specific cutaneous 
manifestations in relation to various internal Malignancies 
4. To study the clinical pattern of cutaneous manifestations among 
patients with internal malignancy. 
5. To study the incidence of genodermatoses among patients of 
internal malignancy with cutaneous manifestations. 
6. To study the prognostic significance of the cutaneous 
manifestations. 
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MATERIALS AND METHODS 
A total number of 750 patients attending the Cancer 
Chemotherapy Out Patient Department and proven Cancer patients 
referred to Dermatology Out Patient Department for various skin 
problems were screened for cutaneous lesions. 
The cancer patients attending the Dermatology O.P.D. were 
mainly referred from other departments like Hematology, Surgery and 
Gastro Enterology. Patients attending the cancer chemotherapy 
O.P.D. were mostly proven cases of malignancy. They were referred 
from other departments in Government General Hospital, Chennai and 
from other hospitals of the state and nearby states. Only those 
confirmed to be having a malignant disease were included. Those 
cases that proved to be negative for malignancy after investigation 
were excluded. 
In patients who had skin lesions, the age, sex, duration of the 
primary neoplasm, the duration between the onset of primary 
neoplasm and the onset of cutaneous lesions, symptoms of cutaneous 
lesions and history of relapse were noted. 
 On clinical examination, importance was given to the features 
like the site of the cutaneous lesions, morphology of the lesion, the 
number and the arrangement and distribution of the lesions were 
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noted. Hematological, radiological and cytological investigations were 
done to confirm the site of primary neoplasm in some patients. Skin 
biopsy of the cutaneous lesions suggestive of Metastases was done 
for histopathological examination. Fine Needle aspiration Cytology was 
done in one case with neck secondary since the patient was very ill. In 
one case with Erythroderma, T-cell marker study was done. The skin 
surface was divided into nine regions as done by Brownstein et al100 
for recording the site of metastasis and the observations are tabulated 
as follows. 
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OBSERVATIONS AND RESULTS 
 Total number of Cancer Patients screened – 750 
 Total number of cases found to have Cutaneous Manifestations–52 
 The incidence of cutaneous manifestations in this study –6.93% 
Age & Sex Incidence  
 The male female ratio in this study was 34: 18 
 Percentage of Male patients with Skin lesions – 65.38 
 Percentage of Female patients with Skin lesions – 34.62 
 In males the youngest patient encountered was a 15 yrs old boy 
while the oldest patient was 75 yrs of age. 
 In Females the Youngest patient encountered was a 14 yrs old 
girl while the oldest patient was 63 yrs of age 
 
Sex Number of cases Percentage (%) 
Male 34 65.38 
Female 18 34.62 
Total 52 100 
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Incidence of internal malignancy with skin manifestations 
  Lymphomas and leukemias were the commonest neoplasm 
producing cutaneous manifestations among all patients followed by 
Carcinoma Breast and Carcinoma Stomach. The other malignancies 
encountered in our study in descending order of frequency were 
Carcinoma Cervix, Carcinoma Prostate, Carcinoma Buccal Mucosa, 
Malignant Melanoma, Seminoma, Carcinoma Oesophagus, Carcinoma 
Pharynx, Hepato Cellular Carcinoma, Astrocytoma, 
Pheochromocytoma, Secondaries liver and neck with unknown 
primary. 
Internal Malignancy Number of 
cases 
Percentage
Non Hodgkin’s Lymphoma 10 19.2 
ALL – 2 
AML – 3 
CLL – 4  
 
 
Leukemia 
 
PCV – 1  
 
 
10 
 
 
 
19.2 
 
Carcinoma Breast 7 13.46 
Carcinoma Stomach 6 11.5 
Carcinoma Cervix 3 5.76 
Carcinoma Prostate 3 5.76 
Carcinoma Buccal Mucosa 3 5.76 
Malignant Melanoma 2 3.84 
Seminoma 1 1.92 
Carcinoma Oesophagus 1 1.92 
Carcinoma Pharynx 1 1.92 
Hepatocellular carcinoma 1 1.92 
Astrocytoma  1 1.92 
Pheochromocytoma 1 1.92 
Secondaries liver 1 1.92 
Secondaries neck 1 1.92 
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Age predilection of Cutaneous Manifestations of Internal 
Malignancy 
  In males, the most patients belonged to 5th and 6th decade.  
 In females, the most patients belonged to 5th decade.  
Male Female Age 
group 
Number of cases Percentage Number 
of cases 
Percentage 
11-20 2 5.8 2 11.11 
21-30 - - - - 
31-40 4 11.7 2 11.11 
41-50 5 14.7 4 22.22 
51-60 11 32.35 9 50.0 
61-70 11 32.35 1 5.5 
71-80 1 2.9 - - 
 34 100 18 100 
 
Sex wise Incidence of Internal Malignancy with skin 
manifestations. 
  Non-Hodgkin’s Lymphoma was the commonest Neoplasm 
producing skin lesions in Male followed by Leukemias and Carcinoma 
Stomach. 
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Internal Malignancy in 
Male 
Number of 
cases 
Percentage 
Non Hodgkin’s Lymphoma 9 26.47 
ALL   - 2 
AML  - 1 
 
Leukemia 
CLL   - 2 
 
 
5 
 
 
14.7 
Carcinoma Stomach 5 14.7 
Carcinoma Prostate 3 8.82 
Carcinoma Buccal Mucosa 3 8.82 
Malignant Melanoma 2 5.88 
Seminoma 1 2.94 
Carcinoma Oesophagus 1 2.94 
Carcinoma Pharynx 1 2.94 
Hepatocellular carcinoma 1 2.94 
Pheochromocytoma 1 2.94 
Secondaries liver 1 2.94 
Secondaries neck 1 2.94 
Total 34 100 
 
In Females, Carcinoma Breast was the commonest neoplasm 
producing skin lesions followed by Leukemias, Carcinoma Cervix, 
Non-Hodgkin’s Lymphoma, Carcinoma Stomach and Astrocytoma in 
descending order of occurrence. 
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Internal Malignancy in 
Female 
Number of 
cases 
Percentage
Carcinoma Breast 7 38.88 
AML  - 
2 
CLL  -  
2 
 
 
Leukemia 
 
PCV - 1 
 
 
5 
 
 
 
27.77 
 
Carcinoma Cervix 3 16.66 
Non-Hodgkin’s 
Lymphoma 
1 5.55 
Carcinoma Stomach 1 5.55 
Astrocytoma 1 5.55 
Total 18 100 
 
Incidence of Cutaneous Manifestations among Internal 
Malignancy patients. 
Cutaneous Metastases was the commonest skin manifestation 
among cancer patients followed by Infections especially Herpes 
Zoster. The other nonspecific cutaneous manifestations encountered 
in the present study, in the descending order of frequency were 
generalized pruritus, multiple eruptive seborrhoeic keratoses, Bullous 
disorders, Erythema Multiforme, Erythroderma, Flushing, Purpura, 
SLE, Pyoderma Gangrenosum, Insect Bite Allergy reactions and 
Lichenoid dermatitis. 
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The incidence of Cutaneous Metastases in this study is 2.66%. 
The incidence of Non-Specific Cutaneous Manifestation is 4.26%. 
Cutaneous Manifestation Number Percentage 
Contiguous         -    6  
Metastases Non Contiguous -   14  
 
20 
 
 
38.46 
 
Herpes Zoster      - 11 
Varicellosis            - 1   
Herpes Simplex   - 1   
 
 
Infections 
Scabies                 - 1   
 
 
14 
 
 
 
26.9 
 
Generalized Pruritus 3 5.76 
 Multiple Eruptive Seborrhoeic Keratoses 3 5.76 
Paraneoplastic  
     Pemphigus          - 2  
 
Bullous 
disorders 
 
Bullous Pemphigoid - 1  
 
3 
 
 
5.76 
 
Erythema Multiforme 1 1.92 
Erythroderma  1 1.92 
Flushing 1 1.92 
Purpura 1 1.92 
Systemic Lupus Erythematosus 1 1.92 
Pyoderma Gangrenosum 1 1.92 
Exaggerated IBA 
lesions-2 (3.84%) 
 
 
Miscellaneous 
 
Lichenoid Dermatitis- 1 
(1.92%) 
3 
 
5.76 
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Sex Predilection of Cutaneous Manifestations of internal 
malignancy 
  In both males and females, cutaneous metastases were the 
commonest presentation followed by Herpes Zoster infection. Non-
contiguous spread is more common in males, whereas contiguous 
spread is more common in females.  
Cutaneous Manifestations Male Female Total 
Metastases 
-Contiguous 
-Non Contiguous 
 
2 
12 
 
4 
2 
 
6 
14 
Infections  
-Herpes Zoster 
-Herpes Simplex 
-Varicellosis 
-Scabies 
 
6 
1 
1 
1 
 
5 
0 
0 
0 
 
11 
1 
1 
1 
Generalized Pruritus 2 1 3 
Multiple Eruptive 
Seborrhoeic Keratoses 
2 1 3 
Bullous disorders 
-Paraneoplastic Pemphigus 
-Bullous Pemphigoid 
 
2 
1 
 
0 
0 
 
2 
1 
Erythema Multiforme 1 0 1 
Erythroderma  1 0 1 
Flushing 1 0 1 
Purpura 0 1 1 
Systemic Lupus 
Erythematosus 
1 0 1 
Pyoderma Gangrenosum 0 1 1 
Miscellaneous: 
Exaggerated IBA lesions 
Lichenoid Dermatitis 
 
0 
0 
 
2 
1 
 
2 
3 
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CUTANEOUS METASTASES 
Contiguous metastases 
Carcinoma Breast (66.6%) was the most common neoplasm 
producing Contiguous metastases to skin. 
Malignancy Metastases to 
Carcinoma  breast – 3 patients Chest wall 
Carcinoma breast® Nipple® 
Carcinoma Buccal Mucosa(L) Cheek(L) 
Amelanotic melanoma- Cheek® Neck® and chest 
 
NON- CONTIGUOUS METASTASES  
Site of Non-Contiguous Metastases: 
The commonest site involved in the descending order of 
occurrence was anterior chest wall followed by anterior wall of the 
abdomen, lower limb, neck, back, upper limb, face, pelvis and scalp. 
Single site was involved in 5 patients. Multiple sites were involved in 9 
patients. 
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SITE OF INVOLVEMENT OF CUTANEOUS METASTASES 
Internal 
Malignancy 
Scalp Face Neck Upper limb Chest
Abdo
men
Back Pelvis Lower limb 
Multiple 
sites 
AML      +     
CLL         +  
NHL  + + + + + + + + + 
NHL     +     + 
Liver 2'  + +  + +    + 
Ca Stomach  +  +  + + +    
NHL    + + + + + + + 
NHL     +     + 
AML    + + +   + + 
Ca Pharynx      + +  +  
NHL 
Relapse 
        + + 
Malignant 
Melanoma 
  +  +      
Ca 
Oesophagus 
 + +  + + + +  + 
Ca Stomach + +  + +     + 
Total 2 4 5 4 10 8 5 3 6 9 
 
Clinical Pattern of Cutaneous Metastases: 
  Skin colored nodule was the common clinical presentation of 
cutaneous metastases, followed by plaques, papules, ulcer and tumor 
in the descending order of occurrence. 
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PATTERN OF CUTANEOUS METASTASES 
Internal Malignancy Papule Nodule Plaque Tumor Ulcer Colour 
Contiguous 
Metastases 
      
Amelanotic Melanoma  + +   E/S 
Ca Buccal mucosa   +   S 
Carcinoma Breast   +  + S 
Carcinoma Breast + + +  + S/E 
Ca Breast + +   + S/E 
Ca Breast + +   + S/E 
Non-Contiguous 
Metastases 
      
AML   +   E 
CLL   +   E 
NHL   +   E 
NHL + +    S 
Liver 2' + +    S 
Ca Stomach   +   + S/E 
NHL  +   + S 
NHL  +  + + S 
AML + +    S 
Ca Pharynx  +    S 
NHL Relapse + + +  + S/E 
Malignant Melanoma  +    S 
Ca Oesophagus   +   Hyper Pig 
Ca Stomach  +   + S/E 
Total 7 14 9 1 9  
 
S – Skin colored ; E – Erythematous ; Hyper pig – Hyper pigmented ; 
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Pattern of Herpes Zoster seen in malignancy patients: 
  Among 11 patients with Herpes Zoster, six patients had single 
dermatomal involvement, two patients had dissemination of Herpes 
Zoster and three patients had multidermatomal involvement. 
Primary 
Malignancy Sex 
Segment 
involved 
Duration of 
skin 
lesions 
complications 
Carcinoma 
Breast(L) 
F C4® 3-4 weeks Keloid, PHN+ 
Carcinoma 
Breast(L) 
F T2,T3,T4 3-4 weeks Hypertrophic 
scar+, PHN+ 
Carcinoma 
Breast® 
F C7 3 weeks Nil 
Carcinoma 
Cervix 
F L3 3 weeks Hypertrophic 
scar+ 
Carcinoma 
Cervix 
F C2,C3,C4 3-4 weeks PHN 
Seminoma® M T4 3 weeks PHN 
Carcinoma 
Buccal 
mucosa(L) 
M T6 3 weeks PHN 
Carcinoma 
Prostate 
M Ramsay Hunt 
Syn & C2,C3,C4
3 weeks PHN 
Carcinoma 
Stomach 
M Cr.III- 
ophthalmic 
3-4 weeks Hypertrophic 
scar+, PHN 
Non-Hodgkins’s 
Lymphoma 
M C2 with 
Dissemination 
 
4-5 weeks Hypertrophic 
scar+ 
CLL M T5 with 
Dissemination 
4-5 weeks Hypertrophic 
scar+ 
PHN – Post  Herpetic Neuralgia  
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Various presentations of Internal Malignancy 
Leukemia: 
  Leukemias had manifested with variety of skin lesions like 
cutaneous metastases, purpura, pruritus, pyoderma Gangrenosum, 
Photosensitivity, herpes Zoster, Varicellosis and exaggerated insect 
bite allergy lesions. 
Skin Manifestations 
Number 
of 
patients 
Percentage 
AML 
Purpura                                       - 1       
Non-Contiguous Metastases      -  2 
 
3 
 
 
30 
 
CLL 
Non-Contiguous Metastases      - 1 
Ex.IBA                                        - 1 
Pyoderma Gangrenosum           - 1 
Herpes Zoster                            - 1 
 
 
4 
 
 
40 
ALL 
Varicellosis                                 - 1 
SLE                                             - 1 
 
2 
 
20 
PRV 
Pruritus 
 
1 
 
10 
Total  10 100 
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Non-Hodgkin’s Lymphoma: Non-contiguous Metastases was the 
common presentation encountered in patients with Lymphomas. 
Skin Manifestations Number of patients Percentage 
Metastases  
Non-Contiguous 
 
5 
 
 
50 
Infections 
              Herpes Zoster     -1 
              Herpes Simplex   -1 
 
2 
 
 
20 
 
Paraneoplastic Pemphigus 1 10 
Erythroderma 1 10 
Erythema Multiforme 1 10 
              Total                        10 100 
 
Carcinoma Breast: 
Carcinoma Breast manifested most commonly as Contiguous 
metastases followed by Herpes zoster infections. 
Skin Manifestations Number of patients Percentage 
Contiguous Metastases 4 57 
Infections:- Herpes Zoster 3 43 
Total 7 100 
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¶
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Carcinoma Stomach  
Multiple Eruptive Seborrhoeic Keratoses and non-contiguous 
cutaneous metastases were the common cutaneous manifestations of 
Carcinoma stomach followed by Herpes Zoster infection and pruritus. 
Skin Manifestations Number of patients Percentage 
Multiple Eruptive Seborrhoeic Keratoses 2 33.33 
Non-Contiguous Metastases: 2 33.33 
Herpes Zoster 1 16.6 
Pruritus 1 16.6 
Total  6 100 
 
Carcinoma Cervix  
Carcinoma Cervix manifested most commonly with Herpes Zoster 
infection followed by exaggerated insect bite allergy lesions. 
Skin Manifestations Number of 
patients 
Percentage  
Herpes Zoster 2 66.66 
Exaggerated IBA 1 33.33 
Total  3 100 
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Carcinoma Buccal Mucosa 
Skin Manifestations Number of 
patients 
Percentage  
Contiguous Cutaneous metastases 1 33.33 
Herpes Zoster 1 33.33 
Scabies  1 33.33 
Total  3 100 
 
Carcinoma Prostate  
Skin Manifestations Number of 
patients 
Percentage  
Herpes Zoster  1 33.33 
Bullous Pemphigoid  1 33.33 
Multiple Eruptive Seborrhoeic keratoses 1 33.33 
Total  3 100 
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Follow Up 
Case 
No. Skin Manifestations Primary Neoplasm
Period of 
Survival after 
the onset of 
cutaneous 
manifestations 
in months. 
Follow 
up 
 Cutaneous Metastases 
30 
Contiguous 
Metastases 
Amelanotic 
melanoma 
 
12/12 
Alive 
31 
Contiguous 
Metastases Ca Buccal mucosa 
7/12 LTF 
32 
Paget’s disease of 
Nipple Carcinoma Breast 
8/12 LTF 
33 
Contiguous 
Metastases Carcinoma Breast 
5/12 LTF 
34 
Contiguous 
Metastases Ca Breast 
4/12 Died* 
35 
Contiguous 
Metastases Ca Breast 
6/12 Died* 
36 
Non-Contiguous 
Metastases AML 
8/12 LTF 
37 
Non-Contiguous 
Metastases CLL 
12/12 Alive 
38 
Non-Contiguous 
Metastases NHL 
12/12 Alive 
39 
Non-Contiguous 
Metastases NHL 
10/12 Alive 
40 
Non-Contiguous 
Metastases Liver 2' 
3/12 Died* 
41 
Non-Contiguous 
Metastases Ca Stomach  
4/12 LTF 
42 
Non-Contiguous 
Metastases NHL 
4/12 Died* 
43 
Non-Contiguous 
Metastases NHL 
5/12 LTF 
44 
Non-Contiguous 
Metastases AML 
3/12 LTF 
45 
Non-Contiguous 
Metastases Ca Pharynx 
4/12 Died* 
46 
Non-Contiguous 
Metastases NHL Relapse 
2/12 Died* 
47 Non-Contiguous Malignant 6/12 Died* 
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Metastases Melanoma 
48 
Non-Contiguous 
Metastases Ca Oesophagus 
6/12 Alive 
49 
Non-Contiguous 
Metastases Ca Stomach 
6/12 Alive 
 Non-Specific Manifestations 
1 flushing Pheochromocytoma 4/12 LTF 
2 Purpura AML 4/12 LTF 
3 Bullous Pemphigoid Ca Prostate 12/12 Alive 
4 
Paraneoplastic 
Pemphigus 2' Neck 
6/12 Died * 
5 Pemphigus vulgaris NHL 8/12 Died* 
6 Erythema Multiforme NHL 12/12 Alive 
7 H.zoster c3 Ca Breast (b/l) 12/12 Alive  
8 H.zoster T1L3 Ca Breast  3/12 LTF 
9 H.zoster C78 ca Breast 12/12 Alive 
10 H.zoster L3 Ca Cervix 2/12 LTF 
11 H.zoster IIICN Ca Cervix 2/12 LTF 
12 H.zoster T3 Seminoma ® 12/12 Alive 
13 H.zoster T4 Ca Buccal mucosa 3/12 LTF 
14 H.zoster RAMSAY Ca Prostate 6/12 LTF 
15 H.zoster IIICN Ca Stomach 5/12 Died* 
16 H.zoster DISSEM NHL 4/12 LTF  
17 H.zoster DISSEM CLL 3/12 Died* 
18 
Herpes simplex 
labialis NHL 
12/12 Alive 
19 Varicellosis ALL 2/12 LTF 
20 Scabies Ca Buccal mucosa 8/12 Alive 
21 Erythroderma Sezary syndrome 12/12 Alive 
22 SLE ALL 4/12 LTF 
23 Pruritus 
Ca Stomach / 2' 
liver 
2/12 Died* 
24 Pruritus HCC 14/365 Died* 
25 Pruritus PCV 6/12 LTF 
26 Seb.keratoses Ca Stomach 4/12 LTF 
27 Seb.keratoses Ca Prostate 6/12 LTF 
28 Seb.keratoses Ca Stomach 5/12 LTF 
29 
Pyoderma 
gangrenosum CLL 
8/12 LTF 
50 Ex. IBA CLL 5/12 LTF 
51 Ex.IBA Ca Cervix 8/12 Alive 
52 Lichenoid dts Astrocytoma  8/12 Alive 
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DISCUSSION 
 In this prospective study of  750 patients with internal 
malignancy, skin changes were found in 52 patients(6.93%) which is 
lower than that of study by Rajagopal et al5(23%). This difference 
could due to the inclusion of Pediatric cases and cases having therapy 
induced skin changes in the later mentioned study.  
 Among 52 patients showing skin changes, 34 patients were 
males (65%) and 18 patients were females (35%). Similar male 
preponderance was also noted in a study by Rajagopal et al5. 
 65% of male patients belonged to the age group of 50-70 yrs.  
More than 50% of female patients belonged to the group of 50-60 yrs 
as in Rajagopal et al5 study. Cutaneous manifestations of internal 
malignancy can arise at any age. However, in keeping with the 
increased incidence of malignant disease in later life, most cutaneous 
manifestations occurred during or after the fifth decade. 
 In males the youngest patient encountered was a 15 yrs old boy, 
a case of ALL while the oldest patient was 75 yrs of age, a case of 
Carcinoma Prostate In Females the Youngest patient encountered 
was a 14 yrs old girl, a case of AML while the oldest patient was 63 yrs 
of age a case of Carcinoma Breast. 
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 In our study, Metastases was the commonest skin lesion among 
malignancy patients with 38.46% followed by Herpes Zoster infection 
with 27%. The other nonspecific cutaneous manifestations 
encountered in the present study, in the descending order of frequency 
were generalized pruritus, multiple eruptive seborrhoeic keratoses, 
Bullous disorders, Erythema Multiforme, Erythroderma, Flushing, 
Purpura, SLE, Pyoderma Gangrenosum, Insect Bite Allergy reactions 
and Lichenoid dermatitis.  
 The internal malignancies with cutaneous manifestations in 
present study were Leukemia (19%), Lymphoma ( 19%), Carcinoma 
Breast (13.46%) and Carcinoma Stomach (11.5%). The less frequent 
causes were Carcinoma Cervix, Carcinoma Prostate, Carcinoma 
Buccal Mucosa, Secondaries neck and liver with unknown primary 
neoplasm, Seminoma, Hepato Cellular Carcinoma, Astrocytoma and 
Pheochromocytoma.  
According to the literature, genodermatoses account for a 
minority of paraneoplastic skin lesions. In contrast, in our study, none 
of the patients had features of associated Geno-Dermatoses.  
Cutaneous Metastases: 
 Cutaneous Metastases formed almost 1/3rd of total cases 
(38.46%).  
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The incidence of Cutaneous Metastases in this study was 
2.66%, which is more than that of Tharakaram Study99 (1.4%). 
The incidence of Non-Specific Cutaneous Manifestation was 
4.26%. 
According to the literature3, the most common internal 
malignancies to give rise to cutaneous metastases are carcinomas of 
the lung and colon in males and carcinoma of the colon and ovary in 
females. Overall, melanomas are the commonest followed by 
carcinoma breast, carcinomas of oral cavity, lungs, colon and ovary. 
However in our study, Non-Hodgkin’s lymphoma was the commonest 
neoplasm to produce cutaneous metastases followed by Carcinoma 
breast, and leukemias.  
 Non contiguous Metastases was more common in males (85%) 
than females (15%), and contiguous spread was more commonly 
encountered in females (66.6%) than males (33.3%). This difference 
could be because the malignancy encountered in both sexes was 
different. 
 The period of interval between the onset of symptoms of the 
primary malignancy and onset of cutaneous metastases ranged from 2 
months to 5 years. The shortest duration was 2 months in a case of 
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AML and the longest time interval was 5 years in a case of Carcinoma 
breast. 
 In present study, Carcinoma Breast was the commonest (66%) 
neoplasm causing direct extension to the skin which corroborates with 
the literature3 followed by Carcinoma Buccal Mucosa and Amelanotic 
Melanoma. 
 Among 4 patients of Carcinoma Breast with contiguous 
metastases, three had recurrence and developed multiple skin colored 
and erythematous papules and nodules. Another Carcinoma Breast 
patient presented with ulcerative plaque over ®nipple and areola with 
history of bleeding and diagnosis of malignancy was possible by 
biopsy in that patient.  
 Non-Hodgkin’s Lymphoma (35.7%) was the commonest 
neoplasm to produce non-Contiguous Metastases followed by Gastro-
intestinal Malignancies (28.5%) and leukemias with (21.4%) especially 
AML Type. Others like Malignant Melanoma, and Secondaries liver 
and neck with unknown primary constitute 7% each.  
  In this study, the commonest site of metastases was the anterior 
chest wall followed by the anterior abdominal wall which corroborates 
with the similar finding observed in the studies by Tharakaram et al99, 
Brownstein et al100 and Rajagopal et al5. 
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 In our study, Skin colored nodule is the commonest clinical 
presentation of distant metastases and most often occurred in multiple 
sites which corroborates with the study by Rajagopal et al5. We also 
encountered plaques, papules, ulcers and tumor in the descending 
order of frequency. Erythematous papules, nodules and plaques, and 
pigmented plaques were also noted in the present study. 
Non-Specific Skin Manifestations associated with Internal 
Malignancy: 
Among non-specific lesions associated with internal 
malignancies, Infection particularly Herpes Zoster stood first with 
(27%), in contrast, Herpes zoster stood second in the study by 
Rajagopal et al5.   
  Carcinoma Breast (27%) was the commonest Malignancy 
associated with Herpes Zoster and Carcinoma Cervix (18%) stood 
second.  
Among 11 patients with Herpes Zoster, six patients had single 
dermatomal involvement, two patients had dissemination of Herpes 
Zoster and 3 patients had multidermatomal involvement. Among six 
patients with single dermatome involvement, one patient had Herpes 
Zoster Ophthalmicus and the remaining five patients had single 
dermatome involvement (C4,C7, T4, T6 and L3). One patient had 
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involvement of Geniculate Ganglion (Ramsay Hunt Syndrome) with 
involvement of C2,C3 & C4. Healing time was prolonged in 6 patients. 
Post Herpetic Neuralgia was the commonest complication found in 
these patients which corroborates with the study by Shanbrom et al102 . 
  According to literature3, the dermatomal distribution of the 
herpes zoster may indicate involvement of the nerve root area with 
Carcinoma Breast metastases. In contrast, In this study, none of the 
patients developed any feature of metastases in the dermatomal 
distribution during the study period. 
  According to literature3, disseminated herpes zoster is 
commonly associated with underlying malignant disease like 
lymphoma and leukemia.  Which is consistent with our study and two 
of our patients with Disseminated Herpes Zoster lesions had NHL and 
CLL. We also encountered an ALL patient with Varicellosis of 
prolonged duration and a Non Hodgkin’s Lymphoma patient with 
recurrent Herpes Simplex Labialis infection. 
  We also encountered Scabies infection in a patient with 
Carcinoma Buccal Mucosa. 
 In present study, we encountered Paraneoplastic Pemphigus in 
two patients. One of the patients was having Non-Hodgkin’s 
Lymphoma which was found to be commonly associated neoplasm 
 
 
68
with Paraneoplastic Pemphigus in a study by Anhalt et al101. Another 
patient developed Paraneoplastic Pemphigus lesion which preceded 
the neck Secondary by 3 months. In this patient, FNAC of neck 
secondary showed atypical squamous cells. Both the patients with 
paraneoplastic pemphigus lesions expired. 
 One of our patient with Carcinoma Prostate developed bullous 
pemphigoid lesions which is also reported in literature4.  
 According to literature3, Erythema Multiforme appears to occur 
more frequently with Acute Leukemias.  In present study, a patient with 
NHL having Erythema Multiforme over chest, abdomen and extremities 
was encountered. It is hard to evaluate, whether it occurred as 
reaction to drugs, radiotherapy or associated infections. 
 In present study, pruritus was noticed in 3 patients with 
Hepatocellular carcinoma, Polycythemia Vera and Carcinoma 
Stomach. Pruritus was observed as a common manifestation among 
internal malignancy patients in the study by RajaGopal et al5. 
  The patient with Hepatocellular carcinoma developed 
generalized intractable itching along with jaundice, not responding to 
conventional antihistamines and USG abdomen helped to diagnose 
the condition. 
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Among other two patients with generalized prirotus, one had 
Polycythemia Rubra Vera and another patient had Carcinoma 
Stomach with liver Secondaries. 
 In present study Multiple Eruptive Seborrhoeic Keratoses 
(MESKs) was seen in three patients. In our study, Carcinoma Stomach 
(66.66%) was the most common primary neoplasm associated with 
MESKs which corroborates with the literature3, followed by Carcinoma 
Prostate. 
  Seborrhoeic keratoses are extremely common in normal 
population also. Proving an uncommon causal relationship between a 
common cancer and a common skin sign was difficult as the number of 
patients in this study were few. 
 In an elderly male with Sezary Syndrome with erythroderma and 
generalized lymphadenopathy, the diagnosis was made by Peripheral 
smear and T cell marker study. 
  In this study, we encountered a patient having pronounced 
flushing involving the central face and upper trunk for the past 2 
months which led to the diagnosis of Pheochromocytoma.  
A known case of AML, presented with multiple purpuric spots 
over the abdomen, thighs and legs. Acute leukemias are mentioned as 
a cause of Purpura in the literature.  
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According to literature3, Systemic Lupus Erythematosus is only 
rarely associated with malignant Neoplasia, most often with lymphoma 
or thymoma. In contrast, in the present study, SLE was found in 
association with ALL.   
In a woman with Pyoderma gangrenosum associated with CLL, 
morphology was that of ulcerative type in contrast to bullous type 
reported in literature3. 
 In present study, exaggerated insect bite allergy reactions were 
noted in two female patients with malignancy like CLL and Carcinoma 
Cervix. It is still not clear, whether the immunological imbalance 
occurring in leukemic patients or the radiotherapy induced 
immunological instability is responsible for such exaggerated insect 
bite allergy lesions. 
 In present study, a patient having Astrocytoma in ® thalamus 
region developed diffuse lichenoid dermatitis throughout the body 
within a period of 2 months duration. The lesions were more prominent 
over exposed parts.  
Prognostic Significance of Cutaneous Manifestations of Internal 
Malignancy 
 The prognostic Significance of the Cutaneous Manifestations 
depends on various factors, whether the Manifestation is specific or 
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non specific, the type of internal Malignancy, the mode of 
interventional therapy and the general immune status of the patient. 
   In our study of cutaneous manifestations with internal 
Malignancy,  
23 out of 52 Patients (44%) were lost for follow up. In the 
remaining 29 patients, 13 patients (44%)  succumbed to their illness.  
  7 patients (54%) showing Specific cutaneous metastases 
expired. Whereas, 6 patients (37%) showing non specific Cutaneous 
Metastases expired. 
Cutaneous Metastases: 
 In our study, 20 out of 52 patients had Cutaneous Metastases. 7 
patients(54%) showing Specific cutaneous metastases expired in the 
period ranging from 2-6 months. 
  The shortest survival period (2 months) was seen in a patient 
who developed recurrence of NHL. Two out of the three patients with 
Carcinoma Breast, who developed recurrence of malignancy after 
surgery, expired in 4 months and 6 months respectively. 
   Except for a patient with NHL relapse, many patients with 
Cutaneous Metastases survived for a minimum of 3 months, which 
corroborates with the study by Reingold. 
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Non-Specific Cutaneous Manifestations: 
  The casual relationship between the Non Specific Cutaneous 
Manifestation and the internal malignancy is very difficult to prove. It 
depends mainly on the type of cutaneous manifestation involved and 
the internal malignancy under study. This was because some 
cutaneous Manifestations are common especially Herpes Zoster & 
Seborrhoeic keratoses, and some malignancies were more common 
like NHL, Leukemias & Carcinoma Breast. Similarly Survival Period is 
also difficult to assess based on Non-Specific Cutaneous 
Manifestation of Internal Malignancy.  
   6 (37%) showing non specific Cutaneous Metastases expired in 
the period ranging from 14 days to 8 months. The Shortest Survival 
(14 days) was noted in a patient with Hepatocellular Carcinoma. Both 
Paraneoplastic Pemphigus expired with in 6 months and 8 months 
respectively. A CLL patient with Disseminated Herpes Zoster also 
Succumbed to the illness with in 3 months.    
Cutaneous Metastases, indicating a sign of recurrence, and 
wide spread metastases had poor prognosis and survival period is 
reduced when compared to others. 
 Among Non-specific manifestations, the Bullous disorders and 
disseminated Infections had poor prognosis. 
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CONCLUSION 
1. The incidence of Cutaneous Manifestations associated with 
internal malignancy is 6.93%  
2. Out of 52 patients having cutaneous Manifestations with internal 
Malignancy, 34 patients were Male (65%) and 18 were female 
(35%). Males and Females above 50 yrs had more cutaneous 
Manifestations associated with internal Malignancy. 
3. The incidence of Cutaneous Metastases in this study was 
2.66%, and the incidence of Non-Specific Cutaneous 
Manifestation was 4.26%. 
4. Lymphomas and Leukemias were the commonest neoplasm 
producing cutaneous manifestations followed by Carcinoma 
Breast and Carcinoma Stomach. Cutaneous Metastases was 
the commonest skin manifestation among Malignancy patients 
followed by Herpes Zoster. 
Non-Contiguous Metastases was more common in males 
whereas Contiguous Metastases was more common in females. 
The period of interval between the onset of symptoms of the 
primary malignancy and onset of cutaneous metastases ranged 
from 2 months in a case of AML to 5 years in a case of 
Carcinoma Breast. Contiguous Cutaneous Metastases was 
more commonly seen with Carcinoma Breast and Non-
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Hodgkin’s Lymphoma was the commonest neoplasm to produce 
non-Contiguous Metastases. 
Skin colored nodule was the commonest clinical presentation of 
cutaneous metastases and most often occurred in multiple sites, 
The commonest site of distant Metastases was Chest, followed 
by abdomen and lower limb. Leukemias had manifested with 
variety of skin lesions like cutaneous metastases, purpura, 
pruritus, pyoderma gangrenousm, Systemic lupus 
erythematosus, herpes Zoster, Varicellosis and exaggerated 
insect bite allergy lesions. Dissemination, Multidermatomal 
involvement, longer healing time, tendency for Keloid formation 
and Post Herpetic Neuralgia was observed in Malignancy 
patients with Herpes Zoster. 
5. Genodermatoses with associated internal malignancy was not 
noted. 
6. Cutaneous metastases indicating recurrence of NHL and 
Carcinoma Breast, the survival period was 2 months and 6 
months respectively. Among cases of Non-Specific cutaneous 
manifestation, the shortest period of survival was 14 days in a 
case of HepatoCellular Carcinoma. 
The prognosis could not be definitely ascertained because of 
small number of cases studied and the large number of drop outs, but 
in general Cutaneous Metastases, the Bullous disorders and 
disseminated Infections had poor prognosis. 
Sezary Syndrome 
 
 
 
 
 
         
 
 
Non – Hodgkin’s Lymphoma with Sezary Syndrome showing diffuse 
Erythroderma, Hyperkeratoses on palms and soles and dystrophic nails. 
 
Sezary Syndrome 
 
HPE of skin showing Pautrier Micro            HPE of lymphnode showing                              
abcess in epidermis and epidermo   widening of interfollicular areas and 
tropism of atypical lymphocytes.                 foamy, pigment laden Macrophages 
.  Immuno Histo Chemistry of skin biopsy 
  
                 
 CD 3 Positive     CD 4+ Positive 
  
      
               CD 43 Positive    CD 30 Negative 
 
Peripheral Buffy coat smear showing Sezary Cells 
Metastatic Breast Carcinoma 
 
Metastatic Breast Carcinoma showing multiple papules, nodules and ulcer over 
anterior chest wall 
 
 
 
Metastatic Breast Carcinoma showing loops and rows of polyhedral cells with 
hyperchromatic and pleomorphic nuclei, and occasional areas of glandular 
formation 
Paget’s Disease of Nipple 
 
 
Carcinoma Breast with ulcerative plaque over nipple and areola, and retraction 
of the nipple 
 
 
 
Metastatic Breast Carcinoma showing Pagetoid cells in the Epidermis 
Metastatic Stomach Carcinoma 
 
 
Metastatic Stomach Carcinoma showing Erythematous nodule over the neck 
 
 
 
Metastatic Stomach Carcinoma showing collection of atypical epithelial cells in 
the upper dermis 
 
Leukemic Deposits 
 
 
Metastatic CLL showing infiltrated plaque over right thigh 
 
  HPE showing clusters of lymphoid  
 cells around skin appendages and  
 subcutaneous tissue 
 
 
Peripheral smear of CLL showing 
mature and large lymphocytes 
Lymphomatous Deposit 
 
Metastatic Non Hodgkin’s Lymphoma with multiple plaques over the neck 
 
 
 
 
Metastatic Non Hodgkin’s Lymphoma showing diffuse sheets of monotonus 
appearing round cells 
 
  
 
Peripheral smear of AML     
showing Myeloblasts and   
nucleated RBC’s 
 
 
 
 
 
 
 
 
Metastatic AML showing 
Myeloid deposits around 
adnexal structures 
 
 
 
 
 
 
 
 
Metastatic Carcinoma Pharynx 
showing Malignant epithelial 
cells in diffuse and nodular 
pattern and separating the 
fibrous tissue. 
 
Herpes Zoster 
 
Carcinoma Stomach with Herpes Zoster Ophthalmicus 
 
 
 
 
 
Tzanck Smear of Herpes Zoster showing Multinucleated Giant Cells 
 
Herpes Zoster 
 
Seminoma with Herpes Zoster(T4) 
 
 
 
 
 
Carcinoma Cervix with Herpes Zoster (C2,C3,C4) 
 
Herpes Zoster 
 
 
Carcinoma Prostate with Ramsay hunt Sundrome. Patient had Lagopthalmos, 
deviation of angle of mouth, obliteration of left side nasal labial furrow and 
herpes zoster infection involving C2,C3 & C4. 
 
 
Keloid formation in Post Herpetic infection scar in a patient with Carcinoma 
Breast 
 
ALL patient with Varicellosis 
 
 
 
 
Carcinoma Buccal Mucosa with Scabies Infection 
Paraneoplastic pemphigus 
 
Neck Secondaries with Paraneoplastic Pemphigus lesion 
 
 
 
 
 
Paraneoplastic Pemphigus showing severe  Tzanck smear showing  
Oral erosions      Acantholytic cell  
 
 
 
 
  
Carcinoma Prostate with Bullous Pemphigoid showing tense bulla over the 
abdomen and ruptured blister over the chest 
  
 
 
CLL with Pyoderma Gangrenosum over ® thigh and ® leg. 
 
 
 Pheochromocytoma with flushing over face and upper chest.and was 
blanchable 
 
 
Carcinoma Stomach with liver Secondaries having Icterus and generlaised 
excoriations marks 
 
  
Carcinoma Stomach with Multiple Eruptive Seborrhoeic Keratoses over face, 
trunk and upper arms. HPE showed Hyperkeratoses and numerous horn cysts. 
 
 
Carcinoma Cervix with Exaggerated Insect Bite Allergy lesions involving flexor 
and extensor surfaces of forearms. 
  
 
  
Astrocytoma with lichenoid dermatitis involving extremities and flexures 
 
 
 
 
 
 
 
HPE of lichenoid dermatitis showed irregular acanthosis, basal cell 
degeneration and lymphocytic infiltrate in the upper dermis 
 
 
  
 
 
 
 
 
 
 
 
 
ALL patient with Photosensitivity(SLE) 
   
 
Non Hodgkin’s Lymphoma having   Metastatic carcinoma stomach 
skin colored nodules over chest and   with ulcerative nodule over (L)  
abdomen      shoulder 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amelonotic Melanoma over right cheek with multiple erythematous and skin 
colored nodules and papules over the neck. 
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PROFORMA 
 
Cutaneous Manifestations of Internal Malignancy 
 
S.No.  : 
Name  :     Age:   Sex: 
Address :     Occupation: 
       OP/IP No. 
       C.No. 
 
Primary Neoplasm: 
Symptoms / Duration : 
System Involved  : 
Type of Neoplasm  : 
 
Date of Diagnosis  : 
 
Investigations  : 
 
 
Cutaneous lesions: 
Symptoms / Duration : 
Morphology   : 
Number   : 
Site    :  
Distribution   : 
Provisional Diagnosis : 
Investigations  : 
Tzanck/KOH smear/ FNAC/Histopathology: 
 
General condition  : 
 
System Examination : 
 
Follow up   : 
